Clinical Trial Update: The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluated the safety and efficacy of topical IDP-108 compared with vehicle for onychomycosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• IDP-108

Snippet

Sponsor: Dow Pharmaceutical Sciences | Conditions: Onychomycosis | Phase 3 | Status: COMPLETED